Polyflex label

Polyflex

Polyflex Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

There is currently no usage information available for this product. We apologize for any inconvenience.

History

There is currently no drug history available for this drug.

Other Information

Polyflex (ampicillin for injectable suspension, veterinary) is a broad-spectrum penicillin which has bactericidal activity against a wide range of common gram-positive and gram-negative bacteria.

Each 25 g vial contains: 25 g ampicillin activity as ampicillin trihydrate, 90 mg methylparaben (as preservative), 10 mg propylparaben (as preservative), 200 mg lecithin, 500 mg povidone, 200 mg sodium chloride, 600 mg sodium citrate anhydrous.

Each 10 g vial contains: 10 g ampicillin activity as ampicillin trihydrate, 36 mg methylparaben (as preservative), 4 mg propylparaben (as preservative), 80 mg lecithin, 200 mg povidone, 80 mg sodium chloride, 240 mg sodium citrate anhydrous.

Polyflex Manufacturers

  • Boehringer Ingelheim Vetmedica, Inc.
    Polyflex | Boehringer Ingelheim Vetmedica, Inc.
    No Recall

    Polyflex | Boehringer Ingelheim Vetmedica, Inc.

    Polyflex | Boehringer Ingelheim Vetmedica, Inc.

    The dosage of Polyflex will vary according to the animal being treated, the severity of the infection and the animal’s response.

    Dogs and Cats — The recommended dose for dogs or cats is 3 mg/lb of body weight administered twice daily by subcutaneous or intramuscular injection.

    Cattle and Calves Including Non-Ruminating (Veal Calves) — From 2 mg to 5 mg/lb of body weight once daily by intramuscular injection. Do not treat for more than 7 days.

    In all species, 3 days treatment is usually adequate, but treatment should be continued for 48 to 72 hours after the animal has become afebrile or asymptomatic.

    The multi-dose dry-filled vials should be reconstituted to the desired concentration by adding the required amount of Sterile Water for Injection, USP, according to label directions. SHAKE WELL.

    After reconstitution this product is stable for 3 months under refrigeration and will be white to pale yellow in color.

    At the time of reconstitution the vial should be dated and the concentration noted on the label.